VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $220,000 | -71.9% | 13,798 | +214.2% | 0.57% | +117.6% |
| Q3 2015 | $784,000 | +165.8% | 4,392 | +231.2% | 0.26% | +133.9% |
| Q2 2015 | $295,000 | -52.2% | 1,326 | -57.3% | 0.11% | -65.9% |
| Q1 2015 | $617,000 | +124.4% | 3,106 | +47.9% | 0.33% | +412.5% |
| Q3 2014 | $275,000 | -60.3% | 2,100 | -60.0% | 0.06% | -58.7% |
| Q1 2014 | $692,000 | +94.9% | 5,254 | +54.5% | 0.16% | -27.9% |
| Q3 2013 | $355,000 | – | 3,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |